Skip to main content
Top
Published in: Critical Care 5/2012

Open Access 01-10-2012 | Research

Oxygen deficit and H2S in hemorrhagic shock in rats

Authors: Andry Van de Louw, Philippe Haouzi

Published in: Critical Care | Issue 5/2012

Login to get access

Abstract

Introduction

Hemorrhagic shock induced O2 deficit triggers inflammation and multiple organ failure (MOF). Endogenous H2S has been proposed to be involved in MOF since plasma H2S concentration appears to increase in various types of shocks and to predict mortality. We tested the hypothesis that H2S increases during hemorrhagic shock associated with O2 deficit, and that enhancing H2S oxidation by hydroxocobalamin could reduce inflammation, O2 deficit or mortality.

Methods

We used a urethane anesthetized rat model, where 25 ml/kg of blood was withdrawn over 30 minutes. O2 deficit, lactic acid, tumor necrosis factor (TNF)-alpha and H2S plasma concentrations (Siegel method) were measured before and after the bleeding protocol in control animals and animals that received 140 mg/kg of hydroxocobalamin. The ability to oxidize exogenous H2S of the plasma and supernatants of the kidney and heart homogenates was determined in vitro.

Results

We found that withdrawing 25 ml/kg of blood led to an average oxygen deficit of 122 ± 23 ml/kg. This O2 deficit was correlated with an increase in the blood lactic acid concentration and mortality. However, the low level of absorbance of the plasma at 670 nm (A670), after adding N, N-Dimethyl-p-phenylenediamine, that is, the method used for H2S determination in previous studies, did not reflect the presence of H2S, but was a marker of plasma turbidity. There was no difference in plasmatic A670 before and after the bleeding protocol, despite the large oxygen deficit. The plasma sampled at the end of bleeding maintained a very large ability to oxidize exogenous H2S (high μM), as did the homogenates of hearts and kidneys harvested just after death. Hydroxocobalamin concentrations increased in the blood in the μM range in the vitamin B12 group, and enhanced the ability of plasma and kidneys to oxidize H2S. Yet, the survival rate, O2 deficit, H2S plasma concentration, blood lactic acid and TNF-alpha levels were not different from the control group.

Conclusions

In the presence of a large O2 deficit, H2S did not increase in the blood in a rat model of untreated hemorrhagic shock. Hydroxocobalamin, while effective against H2S in vitro, did not affect the hemodynamic profile or outcome in our model.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rixen D, Raum M, Holzgraefe B, Sauerland S, Nagelschmidt M, Neugebauer EA: A pig hemorrhagic shock model: oxygen debt and metabolic acidemia as indicators of severity. Shock. 2001, 16: 239-244. 10.1097/00024382-200116030-00012.CrossRefPubMed Rixen D, Raum M, Holzgraefe B, Sauerland S, Nagelschmidt M, Neugebauer EA: A pig hemorrhagic shock model: oxygen debt and metabolic acidemia as indicators of severity. Shock. 2001, 16: 239-244. 10.1097/00024382-200116030-00012.CrossRefPubMed
2.
go back to reference Rixen D, Siegel JH: Bench-to-bedside review: oxygen debt and its metabolic correlates as quantifiers of the severity of hemorrhagic and post-traumatic shock. Crit Care. 2005, 9: 441-453. 10.1186/cc3526.PubMedCentralCrossRefPubMed Rixen D, Siegel JH: Bench-to-bedside review: oxygen debt and its metabolic correlates as quantifiers of the severity of hemorrhagic and post-traumatic shock. Crit Care. 2005, 9: 441-453. 10.1186/cc3526.PubMedCentralCrossRefPubMed
3.
go back to reference Siegel JH, Fabian M, Smith JA, Kingston EP, Steele KA, Wells MR, Kaplan LJ: Oxygen debt criteria quantify the effectiveness of early partial resuscitation after hypovolemic hemorrhagic shock. J Trauma. 2003, 54: 862-880. 10.1097/01.TA.0000066186.97206.39. discussion 880CrossRefPubMed Siegel JH, Fabian M, Smith JA, Kingston EP, Steele KA, Wells MR, Kaplan LJ: Oxygen debt criteria quantify the effectiveness of early partial resuscitation after hypovolemic hemorrhagic shock. J Trauma. 2003, 54: 862-880. 10.1097/01.TA.0000066186.97206.39. discussion 880CrossRefPubMed
4.
go back to reference Dunham CM, Siegel JH, Weireter L, Fabian M, Goodarzi S, Guadalupi P, Gettings L, Linberg SE, Vary TC: Oxygen debt and metabolic acidemia as quantitative predictors of mortality and the severity of the ischemic insult in hemorrhagic shock. Crit Care Med. 1991, 19: 231-243. 10.1097/00003246-199102000-00020.CrossRefPubMed Dunham CM, Siegel JH, Weireter L, Fabian M, Goodarzi S, Guadalupi P, Gettings L, Linberg SE, Vary TC: Oxygen debt and metabolic acidemia as quantitative predictors of mortality and the severity of the ischemic insult in hemorrhagic shock. Crit Care Med. 1991, 19: 231-243. 10.1097/00003246-199102000-00020.CrossRefPubMed
5.
go back to reference Crowell JW, Smith EE: Oxygen deficit and irreversible hemorrhagic shock. Am J Physiol. 1964, 206: 313-316.PubMed Crowell JW, Smith EE: Oxygen deficit and irreversible hemorrhagic shock. Am J Physiol. 1964, 206: 313-316.PubMed
6.
go back to reference Shoemaker WC, Appel PL, Kram HB: Role of oxygen debt in the development of organ failure sepsis, and death in high-risk surgical patients. Chest. 1992, 102: 208-215. 10.1378/chest.102.1.208.CrossRefPubMed Shoemaker WC, Appel PL, Kram HB: Role of oxygen debt in the development of organ failure sepsis, and death in high-risk surgical patients. Chest. 1992, 102: 208-215. 10.1378/chest.102.1.208.CrossRefPubMed
7.
go back to reference Dewar D, Moore FA, Moore EE, Balogh Z: Postinjury multiple organ failure. Injury. 2009, 40: 912-918. 10.1016/j.injury.2009.05.024.CrossRefPubMed Dewar D, Moore FA, Moore EE, Balogh Z: Postinjury multiple organ failure. Injury. 2009, 40: 912-918. 10.1016/j.injury.2009.05.024.CrossRefPubMed
8.
go back to reference Yao YM, Redl H, Bahrami S, Schlag G: The inflammatory basis of trauma/shock-associated multiple organ failure. Inflamm Res. 1998, 47: 201-210. 10.1007/s000110050318.CrossRefPubMed Yao YM, Redl H, Bahrami S, Schlag G: The inflammatory basis of trauma/shock-associated multiple organ failure. Inflamm Res. 1998, 47: 201-210. 10.1007/s000110050318.CrossRefPubMed
9.
go back to reference Jarrar D, Chaudry IH, Wang P: Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches (Review). Int J Mol Med. 1999, 4: 575-583.PubMed Jarrar D, Chaudry IH, Wang P: Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches (Review). Int J Mol Med. 1999, 4: 575-583.PubMed
10.
go back to reference Jastrow KM, Gonzalez EA, McGuire MF, Suliburk JW, Kozar RA, Iyengar S, Motschall DA, McKinley BA, Moore FA, Mercer DW: Early cytokine production risk stratifies trauma patients for multiple organ failure. J Am Coll Surg. 2009, 209: 320-331. 10.1016/j.jamcollsurg.2009.05.002.CrossRefPubMed Jastrow KM, Gonzalez EA, McGuire MF, Suliburk JW, Kozar RA, Iyengar S, Motschall DA, McKinley BA, Moore FA, Mercer DW: Early cytokine production risk stratifies trauma patients for multiple organ failure. J Am Coll Surg. 2009, 209: 320-331. 10.1016/j.jamcollsurg.2009.05.002.CrossRefPubMed
11.
go back to reference Mok YY, Atan MS, Yoke Ping C, Zhong Jing W, Bhatia M, Moochhala S, Moore PK: Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br J Pharmacol. 2004, 143: 881-889. 10.1038/sj.bjp.0706014.PubMedCentralCrossRefPubMed Mok YY, Atan MS, Yoke Ping C, Zhong Jing W, Bhatia M, Moochhala S, Moore PK: Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br J Pharmacol. 2004, 143: 881-889. 10.1038/sj.bjp.0706014.PubMedCentralCrossRefPubMed
12.
go back to reference Mok YY, Moore PK: Hydrogen sulphide is pro-inflammatory in haemorrhagic shock. Inflamm Res. 2008, 57: 512-518. 10.1007/s00011-008-7231-6.CrossRefPubMed Mok YY, Moore PK: Hydrogen sulphide is pro-inflammatory in haemorrhagic shock. Inflamm Res. 2008, 57: 512-518. 10.1007/s00011-008-7231-6.CrossRefPubMed
13.
go back to reference Wagner F, Asfar P, Calzia E, Radermacher P, Szabo C: Bench-to-bedside review: hydrogen sulfide - the third gaseous transmitter: applications for critical care. Crit Care. 2009, 13: 213-10.1186/cc7700.PubMedCentralCrossRefPubMed Wagner F, Asfar P, Calzia E, Radermacher P, Szabo C: Bench-to-bedside review: hydrogen sulfide - the third gaseous transmitter: applications for critical care. Crit Care. 2009, 13: 213-10.1186/cc7700.PubMedCentralCrossRefPubMed
14.
go back to reference Collin M, Anuar FB, Murch O, Bhatia M, Moore PK, Thiemermann C: Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. Br J Pharmacol. 2005, 146: 498-505. 10.1038/sj.bjp.0706367.PubMedCentralCrossRefPubMed Collin M, Anuar FB, Murch O, Bhatia M, Moore PK, Thiemermann C: Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. Br J Pharmacol. 2005, 146: 498-505. 10.1038/sj.bjp.0706367.PubMedCentralCrossRefPubMed
15.
go back to reference Collin M, Thiemermann C: Hydrogen sulfide and sulfite: novel mediators in the pathophysiology of shock and inflammation. Shock. 2005, 24: 595-596. 10.1097/01.shk.0000188328.59770.25.CrossRefPubMed Collin M, Thiemermann C: Hydrogen sulfide and sulfite: novel mediators in the pathophysiology of shock and inflammation. Shock. 2005, 24: 595-596. 10.1097/01.shk.0000188328.59770.25.CrossRefPubMed
16.
go back to reference Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, Anuar FB, Whiteman M, Salto-Tellez M, Moore PK: Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J. 2005, 19: 1196-1198.PubMed Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, Anuar FB, Whiteman M, Salto-Tellez M, Moore PK: Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J. 2005, 19: 1196-1198.PubMed
17.
go back to reference Hui Y, Du J, Tang C, Bin G, Jiang H: Changes in arterial hydrogen sulfide (H(2)S) content during septic shock and endotoxin shock in rats. J Infect. 2003, 47: 155-160. 10.1016/S0163-4453(03)00043-4.CrossRefPubMed Hui Y, Du J, Tang C, Bin G, Jiang H: Changes in arterial hydrogen sulfide (H(2)S) content during septic shock and endotoxin shock in rats. J Infect. 2003, 47: 155-160. 10.1016/S0163-4453(03)00043-4.CrossRefPubMed
18.
go back to reference Goslar T, Mars T, Podbregar M: Total plasma sulfide as a marker of shock severity in nonsurgical adult patients. Shock. 2011, 36: 350-355. 10.1097/SHK.0b013e31822bcfd0.CrossRefPubMed Goslar T, Mars T, Podbregar M: Total plasma sulfide as a marker of shock severity in nonsurgical adult patients. Shock. 2011, 36: 350-355. 10.1097/SHK.0b013e31822bcfd0.CrossRefPubMed
19.
go back to reference Olson KR, Healy MJ, Qin Z, Skovgaard N, Vulesevic B, Duff DW, Whitfield NL, Yang G, Wang R, Perry SF: Hydrogen sulfide as an oxygen sensor in trout gill chemoreceptors. Am J Physiol Regul Integr Comp Physiol. 2008, 295: R669-680. 10.1152/ajpregu.00807.2007.CrossRefPubMed Olson KR, Healy MJ, Qin Z, Skovgaard N, Vulesevic B, Duff DW, Whitfield NL, Yang G, Wang R, Perry SF: Hydrogen sulfide as an oxygen sensor in trout gill chemoreceptors. Am J Physiol Regul Integr Comp Physiol. 2008, 295: R669-680. 10.1152/ajpregu.00807.2007.CrossRefPubMed
20.
go back to reference Whitfield NL, Kreimier EL, Verdial FC, Skovgaard N, Olson KR: Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am J Physiol Regul Integr Comp Physiol. 2008, 294: R1930-1937. 10.1152/ajpregu.00025.2008.CrossRefPubMed Whitfield NL, Kreimier EL, Verdial FC, Skovgaard N, Olson KR: Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am J Physiol Regul Integr Comp Physiol. 2008, 294: R1930-1937. 10.1152/ajpregu.00025.2008.CrossRefPubMed
21.
go back to reference Peng YJ, Nanduri J, Raghuraman G, Souvannakitti D, Gadalla MM, Kumar GK, Snyder SH, Prabhakar NR: H2S mediates O2 sensing in the carotid body. Proc Natl Acad Sci USA. 2010, 107: 10719-10724. 10.1073/pnas.1005866107.PubMedCentralCrossRefPubMed Peng YJ, Nanduri J, Raghuraman G, Souvannakitti D, Gadalla MM, Kumar GK, Snyder SH, Prabhakar NR: H2S mediates O2 sensing in the carotid body. Proc Natl Acad Sci USA. 2010, 107: 10719-10724. 10.1073/pnas.1005866107.PubMedCentralCrossRefPubMed
22.
go back to reference Olson KR: Hydrogen sulfide and oxygen sensing: implications in cardiorespiratory control. J Exp Biol. 2008, 211: 2727-2734. 10.1242/jeb.010066.CrossRefPubMed Olson KR: Hydrogen sulfide and oxygen sensing: implications in cardiorespiratory control. J Exp Biol. 2008, 211: 2727-2734. 10.1242/jeb.010066.CrossRefPubMed
23.
go back to reference Olson KR: Hydrogen sulfide is an oxygen sensor in the carotid body. Respir Physiol Neurobiol. 2011, 179: 103-110. 10.1016/j.resp.2011.09.010.CrossRefPubMed Olson KR: Hydrogen sulfide is an oxygen sensor in the carotid body. Respir Physiol Neurobiol. 2011, 179: 103-110. 10.1016/j.resp.2011.09.010.CrossRefPubMed
24.
go back to reference Van de Louw A, Haouzi P: Inhibitory effects of hyperoxia and methemoglobinemia on H(2)S induced ventilatory stimulation in the rat. Respir Physiol Neurobiol. 2012, 181: 326-334. 10.1016/j.resp.2012.03.018.CrossRefPubMed Van de Louw A, Haouzi P: Inhibitory effects of hyperoxia and methemoglobinemia on H(2)S induced ventilatory stimulation in the rat. Respir Physiol Neurobiol. 2012, 181: 326-334. 10.1016/j.resp.2012.03.018.CrossRefPubMed
25.
go back to reference Haouzi P: Sulfide and methemoglobinemia. Respir Physiol Neurobiol. 2011, 179: 119-120. 10.1016/j.resp.2011.07.002.CrossRef Haouzi P: Sulfide and methemoglobinemia. Respir Physiol Neurobiol. 2011, 179: 119-120. 10.1016/j.resp.2011.07.002.CrossRef
26.
go back to reference Haouzi P, Bell H, Philmon M: Hydrogen sulfide oxidation and the arterial chemoreflex: effect of methemoglobin. Respir Physiol Neurobiol. 2011, 177: 273-283. 10.1016/j.resp.2011.04.025.CrossRefPubMed Haouzi P, Bell H, Philmon M: Hydrogen sulfide oxidation and the arterial chemoreflex: effect of methemoglobin. Respir Physiol Neurobiol. 2011, 177: 273-283. 10.1016/j.resp.2011.04.025.CrossRefPubMed
27.
go back to reference Hegde A, Bhatia M: Hydrogen sulfide in inflammation: friend or foe?. Inflamm Allergy Drug Targets. 2011, 10: 118-122. 10.2174/187152811794776268.CrossRefPubMed Hegde A, Bhatia M: Hydrogen sulfide in inflammation: friend or foe?. Inflamm Allergy Drug Targets. 2011, 10: 118-122. 10.2174/187152811794776268.CrossRefPubMed
28.
go back to reference Furne J, Saeed A, Levitt MD: Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am J Physiol Regul Integr Comp Physiol. 2008, 295: R1479-1485. 10.1152/ajpregu.90566.2008.CrossRefPubMed Furne J, Saeed A, Levitt MD: Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am J Physiol Regul Integr Comp Physiol. 2008, 295: R1479-1485. 10.1152/ajpregu.90566.2008.CrossRefPubMed
29.
go back to reference Haggard HW: The fate of sulfides in the blood. J Biol Chem. 1921, 49: 519-529. Haggard HW: The fate of sulfides in the blood. J Biol Chem. 1921, 49: 519-529.
30.
go back to reference Van de Louw A, Haouzi P: Ferric iron and cobalt (III) compounds to safely decrease H2S in the body?. Antioxid Redox Signal. 2012, Van de Louw A, Haouzi P: Ferric iron and cobalt (III) compounds to safely decrease H2S in the body?. Antioxid Redox Signal. 2012,
31.
go back to reference Haouzi P, Bell H, Van de Louw A: Hypoxia-induced arterial chemoreceptor stimulation and hydrogen sulfide: too much or too little?. Respir Physiol Neurobiol. 2011, 179: 97-102. 10.1016/j.resp.2011.09.009.CrossRefPubMed Haouzi P, Bell H, Van de Louw A: Hypoxia-induced arterial chemoreceptor stimulation and hydrogen sulfide: too much or too little?. Respir Physiol Neurobiol. 2011, 179: 97-102. 10.1016/j.resp.2011.09.009.CrossRefPubMed
32.
go back to reference Chai W, Wang Y, Lin JY, Sun XD, Yao LN, Yang YH, Zhao H, Jiang W, Gao CJ, Ding Q: Exogenous hydrogen sulfide protects against traumatic hemorrhagic shock via attenuation of oxidative stress. J Surg Res. 2011, 176: 210-219.CrossRefPubMed Chai W, Wang Y, Lin JY, Sun XD, Yao LN, Yang YH, Zhao H, Jiang W, Gao CJ, Ding Q: Exogenous hydrogen sulfide protects against traumatic hemorrhagic shock via attenuation of oxidative stress. J Surg Res. 2011, 176: 210-219.CrossRefPubMed
33.
go back to reference Morrison ML, Blackwood JE, Lockett SL, Iwata A, Winn RK, Roth MB: Surviving blood loss using hydrogen sulfide. J Trauma. 2008, 65: 183-188. 10.1097/TA.0b013e3181507579.CrossRefPubMed Morrison ML, Blackwood JE, Lockett SL, Iwata A, Winn RK, Roth MB: Surviving blood loss using hydrogen sulfide. J Trauma. 2008, 65: 183-188. 10.1097/TA.0b013e3181507579.CrossRefPubMed
34.
go back to reference Ganster F, Burban M, de la Bourdonnaye M, Fizanne L, Douay O, Loufrani L, Mercat A, Cales P, Radermacher P, Henrion D, Asfar P, Meziani F: Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats. Crit Care. 2010, 14: R165-PubMedCentralPubMed Ganster F, Burban M, de la Bourdonnaye M, Fizanne L, Douay O, Loufrani L, Mercat A, Cales P, Radermacher P, Henrion D, Asfar P, Meziani F: Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats. Crit Care. 2010, 14: R165-PubMedCentralPubMed
35.
go back to reference Drabek T: Hydrogen sulfide-curiouser and curiouser!. Crit Care Med. 2012, 40: 2255-2256. 10.1097/CCM.0b013e318251507d.CrossRefPubMed Drabek T: Hydrogen sulfide-curiouser and curiouser!. Crit Care Med. 2012, 40: 2255-2256. 10.1097/CCM.0b013e318251507d.CrossRefPubMed
36.
go back to reference Siegel LM: A direct microdetermination for sulfide. Anal Biochem. 1965, 11: 126-132. 10.1016/0003-2697(65)90051-5.CrossRefPubMed Siegel LM: A direct microdetermination for sulfide. Anal Biochem. 1965, 11: 126-132. 10.1016/0003-2697(65)90051-5.CrossRefPubMed
37.
go back to reference Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977, 35: 1-39. 10.1038/bjc.1977.1.PubMedCentralCrossRefPubMed Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977, 35: 1-39. 10.1038/bjc.1977.1.PubMedCentralCrossRefPubMed
38.
go back to reference Taylor JH, Beilman GJ, Conroy MJ, Mulier KE, Myers D, Gruessner A, Hammer BE: Tissue energetics as measured by nuclear magnetic resonance spectroscopy during hemorrhagic shock. Shock. 2004, 21: 58-64.CrossRefPubMed Taylor JH, Beilman GJ, Conroy MJ, Mulier KE, Myers D, Gruessner A, Hammer BE: Tissue energetics as measured by nuclear magnetic resonance spectroscopy during hemorrhagic shock. Shock. 2004, 21: 58-64.CrossRefPubMed
39.
go back to reference Drabek T, Kochanek PM, Stezoski J, Wu X, Bayir H, Morhard RC, Stezoski SW, Tisherman SA: Intravenous hydrogen sulfide does not induce hypothermia or improve survival from hemorrhagic shock in pigs. Shock. 2011, 35: 67-73. 10.1097/SHK.0b013e3181e86f49.CrossRefPubMed Drabek T, Kochanek PM, Stezoski J, Wu X, Bayir H, Morhard RC, Stezoski SW, Tisherman SA: Intravenous hydrogen sulfide does not induce hypothermia or improve survival from hemorrhagic shock in pigs. Shock. 2011, 35: 67-73. 10.1097/SHK.0b013e3181e86f49.CrossRefPubMed
40.
go back to reference Crippen D, Safar P, Snyder C, Porter L: Dying pattern in volume-controlled hemorrhagic shock in awake rats. Resuscitation. 1991, 21: 259-270. 10.1016/0300-9572(91)90051-Y.CrossRefPubMed Crippen D, Safar P, Snyder C, Porter L: Dying pattern in volume-controlled hemorrhagic shock in awake rats. Resuscitation. 1991, 21: 259-270. 10.1016/0300-9572(91)90051-Y.CrossRefPubMed
41.
go back to reference Van der Linden P, Gilbart E, Engelman E, Schmartz D, de Rood M, Vincent JL: Comparison of halothane, isoflurane, alfentanil, and ketamine in experimental septic shock. Anesth Analg. 1990, 70: 608-617.CrossRefPubMed Van der Linden P, Gilbart E, Engelman E, Schmartz D, de Rood M, Vincent JL: Comparison of halothane, isoflurane, alfentanil, and ketamine in experimental septic shock. Anesth Analg. 1990, 70: 608-617.CrossRefPubMed
42.
go back to reference Armstrong JM, Lefevre-Borg F, Scatton B, Cavero I: Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat. J Pharmacol Exp Ther. 1982, 223: 524-535.PubMed Armstrong JM, Lefevre-Borg F, Scatton B, Cavero I: Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat. J Pharmacol Exp Ther. 1982, 223: 524-535.PubMed
43.
go back to reference Mortola JP: Implications of hypoxic hypometabolism during mammalian ontogenesis. Respir Physiol Neurobiol. 2004, 141: 345-356. 10.1016/j.resp.2004.01.011.CrossRefPubMed Mortola JP: Implications of hypoxic hypometabolism during mammalian ontogenesis. Respir Physiol Neurobiol. 2004, 141: 345-356. 10.1016/j.resp.2004.01.011.CrossRefPubMed
44.
go back to reference Gautier H: Interactions among metabolic rate, hypoxia, and control of breathing. J Appl Physiol. 1996, 81: 521-527.PubMed Gautier H: Interactions among metabolic rate, hypoxia, and control of breathing. J Appl Physiol. 1996, 81: 521-527.PubMed
45.
go back to reference Frappell P, Lanthier C, Baudinette RV, Mortola JP: Metabolism and ventilation in acute hypoxia: a comparative analysis in small mammalian species. Am J Physiol. 1992, 262: R1040-1046.PubMed Frappell P, Lanthier C, Baudinette RV, Mortola JP: Metabolism and ventilation in acute hypoxia: a comparative analysis in small mammalian species. Am J Physiol. 1992, 262: R1040-1046.PubMed
46.
go back to reference Haouzi P: Ventilatory and metabolic effects of exogenous hydrogen sulfide. Respir Physiol Neurobiol. 2012, Haouzi P: Ventilatory and metabolic effects of exogenous hydrogen sulfide. Respir Physiol Neurobiol. 2012,
47.
go back to reference Shepherd RE, Gollnick PD: Oxygen uptake of rats at different work intensities. Pflugers Arch. 1976, 362: 219-222. 10.1007/BF00581173.CrossRefPubMed Shepherd RE, Gollnick PD: Oxygen uptake of rats at different work intensities. Pflugers Arch. 1976, 362: 219-222. 10.1007/BF00581173.CrossRefPubMed
48.
go back to reference Shepherd AP, Pawlik W, Mailman D, Burks TF, Jacobson ED: Effects of vasoconstrictors on intestinal vascular resistance and oxygen extraction. Am J Physiol. 1976, 230: 298-305.PubMed Shepherd AP, Pawlik W, Mailman D, Burks TF, Jacobson ED: Effects of vasoconstrictors on intestinal vascular resistance and oxygen extraction. Am J Physiol. 1976, 230: 298-305.PubMed
49.
go back to reference Janssen BJ, De Celle T, Debets JJ, Brouns AE, Callahan MF, Smith TL: Effects of anesthetics on systemic hemodynamics in mice. Am J Physiol Heart Circ Physiol. 2004, 287: H1618-1624. 10.1152/ajpheart.01192.2003.CrossRefPubMed Janssen BJ, De Celle T, Debets JJ, Brouns AE, Callahan MF, Smith TL: Effects of anesthetics on systemic hemodynamics in mice. Am J Physiol Heart Circ Physiol. 2004, 287: H1618-1624. 10.1152/ajpheart.01192.2003.CrossRefPubMed
50.
go back to reference Haouzi P, Bell HJ: Respiratory effects of changing the volume load imposed on the peripheral venous system. Respir Physiol Neurobiol. 2010, 171: 175-180. 10.1016/j.resp.2010.04.007.CrossRefPubMed Haouzi P, Bell HJ: Respiratory effects of changing the volume load imposed on the peripheral venous system. Respir Physiol Neurobiol. 2010, 171: 175-180. 10.1016/j.resp.2010.04.007.CrossRefPubMed
51.
go back to reference Beaver WL, Wasserman K, Whipp BJ: A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol. 1986, 60: 2020-2027.PubMed Beaver WL, Wasserman K, Whipp BJ: A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol. 1986, 60: 2020-2027.PubMed
52.
go back to reference Kage S, Kashimura S, Ikeda H, Kudo K, Ikeda N: Fatal and nonfatal poisoning by hydrogen sulfide at an industrial waste site. J Forensic Sci. 2002, 47: 652-655.PubMed Kage S, Kashimura S, Ikeda H, Kudo K, Ikeda N: Fatal and nonfatal poisoning by hydrogen sulfide at an industrial waste site. J Forensic Sci. 2002, 47: 652-655.PubMed
53.
go back to reference Hughes MN, Centelles MN, Moore KP: Making and working with hydrogen sulfide: The chemistry and generation of hydrogen sulfide in vitro and its measurement in vivo: a review. Free Radic Biol Med. 2009, 47: 1346-1353. 10.1016/j.freeradbiomed.2009.09.018.CrossRefPubMed Hughes MN, Centelles MN, Moore KP: Making and working with hydrogen sulfide: The chemistry and generation of hydrogen sulfide in vitro and its measurement in vivo: a review. Free Radic Biol Med. 2009, 47: 1346-1353. 10.1016/j.freeradbiomed.2009.09.018.CrossRefPubMed
54.
go back to reference Wintner EA, Deckwerth TL, Langston W, Bengtsson A, Leviten D, Hill P, Insko MA, Dumpit R, VandenEkart E, Toombs CF, Szabo C: A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood. Br J Pharmacol. 2010, 160: 941-957. 10.1111/j.1476-5381.2010.00704.x.PubMedCentralCrossRefPubMed Wintner EA, Deckwerth TL, Langston W, Bengtsson A, Leviten D, Hill P, Insko MA, Dumpit R, VandenEkart E, Toombs CF, Szabo C: A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood. Br J Pharmacol. 2010, 160: 941-957. 10.1111/j.1476-5381.2010.00704.x.PubMedCentralCrossRefPubMed
55.
go back to reference Tokuda K, Kida K, Marutani E, Crimi E, Bougaki M, Khatri A, Kimura H, Ichinose F: Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice. Antioxid Redox Signal. 2012, 17: 11-21. 10.1089/ars.2011.4363.PubMedCentralCrossRefPubMed Tokuda K, Kida K, Marutani E, Crimi E, Bougaki M, Khatri A, Kimura H, Ichinose F: Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice. Antioxid Redox Signal. 2012, 17: 11-21. 10.1089/ars.2011.4363.PubMedCentralCrossRefPubMed
56.
go back to reference Deleon ER, Stoy GF, Olson KR: Passive loss of hydrogen sulfide in biological experiments. Anal Biochem. 2012, 421: 203-207. 10.1016/j.ab.2011.10.016.CrossRefPubMed Deleon ER, Stoy GF, Olson KR: Passive loss of hydrogen sulfide in biological experiments. Anal Biochem. 2012, 421: 203-207. 10.1016/j.ab.2011.10.016.CrossRefPubMed
57.
go back to reference Truong DH, Mihajlovic A, Gunness P, Hindmarsh W, O'Brien PJ: Prevention of hydrogen sulfide (H2S)-induced mouse lethality and cytotoxicity by hydroxocobalamin (vitamin B(12a)). Toxicology. 2007, 242: 16-22. 10.1016/j.tox.2007.09.009.CrossRefPubMed Truong DH, Mihajlovic A, Gunness P, Hindmarsh W, O'Brien PJ: Prevention of hydrogen sulfide (H2S)-induced mouse lethality and cytotoxicity by hydroxocobalamin (vitamin B(12a)). Toxicology. 2007, 242: 16-22. 10.1016/j.tox.2007.09.009.CrossRefPubMed
58.
go back to reference de La Coussaye JE, Houeto P, Sandouk P, Levillain P, Sassine A, Riou B: Pharmacokinetics of hydroxocobalamin in dogs. J Neurosurg Anesthesiol. 1994, 6: 111-115.CrossRefPubMed de La Coussaye JE, Houeto P, Sandouk P, Levillain P, Sassine A, Riou B: Pharmacokinetics of hydroxocobalamin in dogs. J Neurosurg Anesthesiol. 1994, 6: 111-115.CrossRefPubMed
59.
go back to reference Slot WB, Merkus FW, Van Deventer SJ, Tytgat GN: Normalization of plasma vitamin B12 concentration by intranasal hydroxocobalamin in vitamin B12-deficient patients. Gastroenterology. 1997, 113: 430-433. 10.1053/gast.1997.v113.pm9247460.CrossRefPubMed Slot WB, Merkus FW, Van Deventer SJ, Tytgat GN: Normalization of plasma vitamin B12 concentration by intranasal hydroxocobalamin in vitamin B12-deficient patients. Gastroenterology. 1997, 113: 430-433. 10.1053/gast.1997.v113.pm9247460.CrossRefPubMed
60.
go back to reference Linnell JC, Mackenzie HM, Wilson J, Matthews DM: Patterns of plasma cobalamins in control subjects and in cases of vitamin B12 deficiency. J Clin Pathol. 1969, 22: 545-550. 10.1136/jcp.22.5.545.PubMedCentralCrossRefPubMed Linnell JC, Mackenzie HM, Wilson J, Matthews DM: Patterns of plasma cobalamins in control subjects and in cases of vitamin B12 deficiency. J Clin Pathol. 1969, 22: 545-550. 10.1136/jcp.22.5.545.PubMedCentralCrossRefPubMed
61.
go back to reference Olson KR: "Hydrogen sulfide oxidation and the arterial chemoreflex: effect of methemoglobin" by Haouzi et al. [Respir. Physiol. Neurobiol. (2011)]. Respir Physiol Neurobiol. 2011, 179: 121-10.1016/j.resp.2011.07.003. author reply 119-120CrossRefPubMed Olson KR: "Hydrogen sulfide oxidation and the arterial chemoreflex: effect of methemoglobin" by Haouzi et al. [Respir. Physiol. Neurobiol. (2011)]. Respir Physiol Neurobiol. 2011, 179: 121-10.1016/j.resp.2011.07.003. author reply 119-120CrossRefPubMed
Metadata
Title
Oxygen deficit and H2S in hemorrhagic shock in rats
Authors
Andry Van de Louw
Philippe Haouzi
Publication date
01-10-2012
Publisher
BioMed Central
Published in
Critical Care / Issue 5/2012
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc11661

Other articles of this Issue 5/2012

Critical Care 5/2012 Go to the issue